Background: Telomerase is a speci®c enzyme that appears to have a key role in cellular senescence and the progression of neoplastic tissue. High telomerase activity has been found in several cancers, but not in most normal and benign tissue. Little is known about the in¯uence of telomerase on the abnormal growth associated with hyperparathyroidism. Objective: To analyse telomerase activity in parathyroid tissue obtained from 29 patients undergoing surgery for primary hyperparathyroidism. Design: Tissue for telomerase activity measurements was collected from six hyperplastic, 20 adenomatous and 22 normal parathyroid glands. Methods: The highly sensitive PCR-based telomeric repeat ampli®cation protocol, TRAP, combined with ELISA, was used to detect telomerase activity in tissue extracts containing 3.0 mg protein.
Introduction
Primary hyperparathyroidism is the syndrome caused by increased secretion of parathyroid hormone as a result of parathyroid hyperplasia, adenoma or, more rarely, carcinoma; adenomas account for 80±90% of all cases. The diagnosis is based on histopathological parameters; however, the distinction between the lesions can be problematic (1) . To enhance the understanding of parathyroid pathogenesis, attention has been focused on factors that might in¯uence the progression. Oncogene overexpression or loss of suppressor genes seem to be crucial, but the exact genes involved remain to be identi®ed. Recent studies have investigated the roles of telomeres and telomerase in benign and malignant tumours (2±4) and it has been stated that telomerase might be a useful complement to microscopic cytopathology in the detection of malignant cells in small tissue biopsies (5) . Telomeres are specialized segments of DNA found at the ends of chromosomes, which have been proposed to have a key role in cellular senescence. They shorten continuously during cell replication, and when they decline to a critical length the cell will stop dividing and eventually die. Telomerase is a speci®c enzyme that synthesizes telomeric DNA onto the ends of chromosomes, thereby preventing telomere shortening. Previous research shows that most normal and benign cells lack telomerase activity, but in a majority of malignant tumours telomerase is activated (2±4). Recently, a highly sensitive PCR-based assay called the telomeric repeat ampli®cation protocol (TRAP) has been developed to measure telomerase activity (6) .
To our knowledge, there is only one study to date that has measured telomerase activity in parathyroid tissue. Results from this study (7) showed that telomerase was activated in carcinomatous tissue, but not in hyperplastic, adenomatous and normal parathyroid tissue. In the present study we wanted to analyse telomerase activity in a larger material. Using the TRAP assay, followed by ELISA, we measured telomerase activity in adenomatous, hyperplastic and macroscopically normal parathyroid specimens from a total of 29 consecutive patients. Because less than 1% of primary hyperparathyroidism is due to a carcinoma, no malignant tissue was available for this study. Results showed that all tissues were negative for telomerase activity.
Material and methods

Ethics
This study was approved by the ethics committee for human research in Linko Èping, Sweden. Written informed consent was obtained from each patient before their entry to the study.
Tissue samples
Biopsies of parathyroid hyperplasias n 6 and adenomas n 20 were collected from patients undergoing parathyroidectomy for hyperparathyroidism. Normal tissue was obtained either at the same time as pathological tissue n 19Y or from patients in whom no pathological gland was available for telomerase analysis n 3X The distribution of patients and tissues is detailed in Table 1 . After peroperative histopathological diagnosis, the pathological gland(s) were resected and transported on ice to the laboratory, where 10±20 mg samples were embedded in cryomount (Histolab, Gothenburg, Sweden) and snapfrozen in liquid nitrogen. Ten consecutive 10 mm sections were transferred to a sterile tube, snap-frozen in liquid nitrogen and stored at 270 8C. Normal tissue was sectioned from the frozen blocks prepared for peroperative examination. To verify the peroperative diagnoses, one part of each specimen was ®xed in formalin and stained with haematoxylin and eosin for a de®nitive histopathological examination.
Telomerase assay
Telomerase activity was measured using the Telomerase PCR ELISA kit (Roche Diagnostics, Mannheim, Germany). The frozen sections were added to 100 ml lysis buffer and incubated on ice. After centrifugation, the supernatants were collected and protein concentrations were determined by the Lowry assay (8) . The extracts were snap-frozen and stored at 270 8C before telomerase analysis.
Cell extracts containing 3.0 mg protein were used for PCR ampli®cation and all samples were run in duplicate. A positive control (enclosed with the kit) and a negative control (consisting of RNase-free water added to lysis buffer) were included in each analysis. In the ®rst step, telomeric repeats (TTAGGG) were added to a biotin-labelled primer by telomerase in the sample. In the second step these elongation products were ampli®ed by PCR. The PCR product was denatured and hybridized to a digoxigenin (DIG)-labelled telomeric repeat-speci®c detection probe and bound to a streptavidin-coated microtitre plate via the biotin-labelled primer. The immobilized PCR product was detected with a peroxidase-conjugated antibody against DIG and ®nally visualized by incubation with tetramethyl benzidine. The absorbance of the coloured reaction product was measured at 450 nm, with a reference wavelength of 690 nm, using an ELISA microtitre plate reader (Anthos htIII, Anthos, Labtec Instruments, Saltzburg, Germany). The mean of the readings of the negative controls was subtracted from those of the samples. Samples were regarded as telomerase-positive if the difference in absorbance, A 450 nm 2 A 690 nm Y was greater than 0.20 units. Samples with TRAP results between 0.10 and 0.19 units were further analysed with 6.0 mg protein.
Results
A total of 48 frozen samples of adenomatous, hyperplastic and morphologically normal parathyroid tissue were analysed for telomerase activity. All specimens stained with haematoxylin and eosin were morphologically judged and the histopathological diagnoses are presented in Table 1 . All tissues were negative for telomerase activity (Table 2) , whereas the positive control exhibited high telomerase activity. Repeated analysis of 12 samples with 6.0 mg protein gave no change in TRAP results. In one case (no. 20) a lymph node was sent for peroperative cryopreservation and histopathological examination. This gland was telomerase-positive.
Discussion
Primary hyperparathyroidism is a syndrome caused by excessive secretion of parathyroid hormone as a result of parathyroid hyperplasia, adenoma or, in rare cases, carcinoma. The classical features of adenoma are expansile growth, reduced or nil parenchymatous fat, cellular pleomorphism and presence of normal parathyroid tissue outside the capsule (1). By de®nition, parathyroid hyperplasia affects more than one gland and is most often a diffuse growth, although it can be nodular. When nodular, the only criterion which discriminates hyperplasia from adenoma is multiplegland vs single-gland disease, and as well-de®ned morphological criteria for benign neoplasia are lacking, classical terminology can be disputed. The terms singlegland and multiple-gland disease have recently been proposed for nomenclature, which is in good concordance with clinical, therapeutic and prognostic knowledge. It has been suggested that parathyroid adenomas might arise from proliferating micronodules in hyperplasias (9) . It has also been questioned whether adenomas progress to carcinomas or if the two entities are independent lesions with no pathogenetic relation. The underlying molecular basis of parathyroid pathogenesis is only partially understood. A disturbed balance between cell proliferation and apoptosis might play an important part, and several molecules have been assessed for their contribution. To date, mutations in the oncogenes cyclin D1/PRAD1 and MEN1 have been implicated to alter the growth regulation of adenomatous parathyroid cells (10) . Loss of calcium sensitivity is another event discussed, however, mutations of the calcium-sensing receptor gene have not yet been found (10) . Complete inactivation of the retinoblastoma (RB) tumour supressor gene (11) and abnormalities in the genes bcl-2, p53 and MIB-1 (12, 13) have also been reported to in¯uence the proliferation. However, most of these markers are not easily applicable and clear criteria to differentiate the three entities are not yet available.
Telomerase activation appears to be an important step in the progression of an aggressive phenotype of epithelial parathyroid cells and seems to be required for the growth of at least some immortal cell types. Several investigators have detected telomerase activity in different malignant tissues (2±4), but not in benign or normal tissue, except for haematopoietic stem cells (14) , basal cells of the epidermis (15) , intestinal crypt cells (16) and activated lymphocytes (14) , and telomerase expression is now widely accepted as a marker for malignant disease. However, because lymphocytes have detectable telomerase activity, lymphocytic in®l-trates in the analysed tissue can lead to false-positive results. Therefore, it is of major importance to judge the telomerase result together with a careful morphological review for evidence of in¯ammatory in®ltrates. In the present study, one specimen sent for analysis had high telomerase activity; when examined morphologically, it appeared to be a lymph node rather than parathyroid tissue, and was therefore excluded from the material.
A recent study (7) reported one case in which carcinomatous parathyroid tissue showed high telomerase activity, whereas normal, hyperplastic and adenomatous tissue were telomerase-negative. In the present study, we have con®rmed this result in a larger number of patients, by showing that normal, hyperplastic and adenomatous parathyroid tissue were not telomerase-positive. In the perspective of the above cited dif®culties in mapping parathyroid pathogenesis, these results might have great theoretical signi®cance.
In conclusion, telomerase is an enzyme known to enhance cell proliferation and progression of neoplastic tissue. Our ®ndings indicate that telomerase activity is not involved in the abnormal growth associated with hyperparathyroidism. This observation contributes to the understanding of parathyroid pathogenesis, although the underlying mechanisms remain to be determined. 
